TheStreet Ratings

10 Best Healthcare Equipment Stocks for

Top Rated Stocks

Every day TheStreet Ratings produces a list of the top rated stocks. These 10 healthcare equipment stocks are rated highest by TheStreet Ratings' value-focused stock rating model.

Equity Top: Healthcare Equipment


Source: TheStreet Ratings

Best Investments for

Healthcare Equipment

Thursday's parade of deals seem to answer a question that's been bugging health care investors for most of 2016: why haven't retreating biotech valuations sparked an uptick in M&A activity?
4/28/16 1:30PM
It's almost cruel to see Al Mann being forced back into the CEO role at MannKind, but the company's near-total collapse demands it.
11/20/15 10:36AM
The signal of activity Sage Therapeutics sees with SAGE-547 in essential tremor may turn out to be real or a mirage.
9/3/15 6:01AM
Titan and its partner will resubmit Probuphine for FDA approval later this year.
6/8/15 7:01AM
As the CEO of a struggling stem-cell therapy company, Hedrick needs to don brightly colored pom-poms just to grab investors' attention.
4/8/15 2:51PM
Plans to seek U.S. approval for the Ocular device, known as OTX-DP are now up in the air.
4/6/15 5:22PM
In April, Celladon is expecting results from a mid-stage study of a gene therapy aiming to improve the pumping ability of the heart in patients with advanced heart failure.
3/25/15 10:06AM
Ocular hasn't conducted clinical trials that would demonstrate that OTX-DP is any better than eye drops in reducing swelling and pain in the eye.
3/10/15 10:17AM
The Securities and Exchange Commission's top cop wants drug companies to be more transparent with investors about their dealings with the U.S. Food and Drug Administration.
3/4/15 1:08PM
Biotech columnist Adam Feuerstein answers readers' questions about health care.
1/23/15 6:00AM
The timing of the Afrezza commercial launch is still a mystery following Sanofi's presentation.
1/12/15 1:35PM
Good calls: Vertex, InterMune, Chelsea, Galena, Exact Sciences. The bad calls: Avanir, Amarin, Exelixis and the bursting biotech stock bubble.
12/19/14 9:02AM
Biotech columnist Adam Feuerstein answers readers' questions about health care.
12/5/14 6:00AM
Biotech columnist Adam Feuerstein answers readers' questions about health care.
11/21/14 6:00AM
Not everyone is convinced that the new Sanofi CEO will remain committed to MannKind and its inhaled insulin Afrezza.
11/4/14 1:40PM